Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
Tackenberg B, Metz A, Unger M, Schimke N, Passow S, Hoeffken H, Hoffmann GF, Müller U, Nolte D, Oertel WH, Eggert K, Möller JC. Tackenberg B, et al. Among authors: eggert k. Mov Disord. 2007 Apr 30;22(6):900-2. doi: 10.1002/mds.21462. Mov Disord. 2007. PMID: 17377924 No abstract available.
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study.
Borm CDJM, Krismer F, Wenning GK, Seppi K, Poewe W, Pellecchia MT, Barone P, Johnsen EL, Østergaard K, Gurevich T, Djaldetti R, Sambati L, Cortelli P, Petrović I, Kostić VS, Brožová H, Růžička E, Marti MJ, Tolosa E, Canesi M, Post B, Nonnekes J, Bloem BR; European MSA Study Group (EMSA-SG). Borm CDJM, et al. Parkinsonism Relat Disord. 2018 Nov;56:33-40. doi: 10.1016/j.parkreldis.2018.06.015. Epub 2018 Jun 8. Parkinsonism Relat Disord. 2018. PMID: 29910157
Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomised, placebo-controlled trial.
Trenkwalder C, Chaudhuri KR, Martinez-Martin P, Rascol O, Ehret R, Vališ M, Sátori M, Krygowska-Wajs A, Marti MJ, Reimer K, Oksche A, Lomax M, DeCesare J, Hopp M; PANDA study group. Trenkwalder C, et al. Lancet Neurol. 2015 Dec;14(12):1161-70. doi: 10.1016/S1474-4422(15)00243-4. Epub 2015 Oct 19. Lancet Neurol. 2015. PMID: 26494524 Clinical Trial.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Costs of drug treatment in Parkinson's disease.
Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Dodel RC, et al. Among authors: eggert km. Mov Disord. 1998 Mar;13(2):249-54. doi: 10.1002/mds.870130209. Mov Disord. 1998. PMID: 9539337
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
Geser F, Wenning GK, Seppi K, Stampfer-Kountchev M, Scherfler C, Sawires M, Frick C, Ndayisaba JP, Ulmer H, Pellecchia MT, Barone P, Kim HT, Hooker J, Quinn NP, Cardozo A, Tolosa E, Abele M, Klockgether T, Østergaard K, Dupont E, Schimke N, Eggert KM, Oertel W, Djaldetti R, Poewe W; European MSA Study Group. Geser F, et al. Among authors: eggert km. Mov Disord. 2006 Feb;21(2):179-86. doi: 10.1002/mds.20678. Mov Disord. 2006. PMID: 16161136
Health-related quality of life in multiple system atrophy.
Schrag A, Geser F, Stampfer-Kountchev M, Seppi K, Sawires M, Köllensperger M, Scherfler C, Quinn N, Pellecchia MT, Barone P, Del Sorbo F, Albanese A, Ostergaard K, Dupont E, Cardozo A, Tolosa E, Nilsson CF, Widner H, Lindvall O, Giladi N, Gurevich T, Daniels C, Deuschl G, Coelho M, Sampaio C, Abele M, Klockgether T, Schimke N, Eggert KM, Oertel W, Djaldetti R, Colosimo C, Meco G, Poewe W, Wenning GK; European MSA-Study Group. Schrag A, et al. Among authors: eggert km. Mov Disord. 2006 Jun;21(6):809-15. doi: 10.1002/mds.20808. Mov Disord. 2006. PMID: 16502399
124 results